Clinical trials
End Stage Renal Disease clinical trials
Below are recruiting end stage renal disease clinical trials, each written for real people, not researchers. We’re tracking 145 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06249932RecruitingPhase 4
Empagliflozin for heart failure and end-stage kidney disease
This trial tests whether empagliflozin, a medication for heart failure, can help people who also have end-stage kidney disease and are on dialysis. It aims to see if the drug improves heart function in this group.
Hsinchu, TaiwanAges 20 years+ - NCT06249945RecruitingPhase 4
Empagliflozin for heart failure with preserved ejection fraction and dialysis
This trial tests whether a medicine called empagliflozin (used for diabetes and heart failure) can help people with both heart failure (with preserved pumping ability) and end-stage kidney disease who are on dialysis. The study looks at how the drug affects heart function and overall well-being.
HsinchuAges 20 years+ - NCT07559396RecruitingPhase 1
Safety study of INCB123667 in adults with severe kidney disease
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
Miami Lakes, FloridaAges 18–85 - NCT06597201RecruitingPhase 4
Testing Amino Acid Dialysis Solution for Malnutrition on Peritoneal Dialysis
This trial tests a special peritoneal dialysis solution with amino acids (protein building blocks) to improve nutrition in people on CAPD who are malnourished. It might help boost your protein levels and overall health.
Hefei, AnhuiAges 18–75 - NCT07511283Recruiting
Calciphylaxis study in kidney disease patients
This study looks at a rare condition called calciphylaxis (hardening of small blood vessels) that can happen in people with chronic kidney disease. It aims to learn more about what causes it and how to help those affected.
OdenseAges 18 years+ - NCT06664125RecruitingPhase 2
New drug for high phosphorus in dialysis patients
This trial tests a new drug, JMKX003002, to lower high phosphorus levels in people with end-stage kidney disease who are on hemodialysis. If you have trouble controlling your phosphorus, this treatment might help.
Guangzhou, GuangdongAges 18 years+ - NCT07405099Enrolling by invitation
Pancreas surgery risks in kidney failure patients
This study looks at the risks of pancreas surgery in people with end-stage kidney disease (kidney failure). It aims to help doctors understand how safe these surgeries are for patients on dialysis or with kidney problems.
Ages 20–75 - NCT07385651Recruiting
Cool storage for donated kidneys
This trial compares storing donated kidneys at 10 degrees Celsius (a cooler temperature) instead of the usual ice storage. It tests if this might help the kidney stay healthier before transplant.
Nashville, TennesseeAges 18 years+ - NCT06836206RecruitingPhase 1/Phase 2
Gum arabic and kidney function in dialysis patients
This trial tests if taking gum arabic, a natural fiber, can help preserve the remaining kidney function in adults on dialysis. If you produce at least 200 ml of urine a day, this study might help you learn about a possible way to protect your kidneys.
Abu DhabiAges 18 years+ - NCT06402851RecruitingPhase 4
Blood thinner or none for atrial fibrillation with dialysis
This trial compares two types of blood thinners (vitamin K antagonists and factor Xa inhibitors) versus no blood thinner in people with atrial fibrillation who are on dialysis or have very advanced kidney disease. It aims to see which option is safest and most effective for preventing strokes and bleeds.
Salvador, Estado de BahiaAges 18 years+ - NCT07370441Enrolling by invitationPhase 4
Amino acid dialysis fluid for better nutrition
This trial tests a special dialysis fluid with amino acids (building blocks of protein) to see if it helps improve nutrition in people on peritoneal dialysis who have low protein levels. If you qualify, it may help boost your nutrition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07361146Recruiting
Physical therapy during or before dialysis: a comparison
This study compares doing physical therapy during your dialysis session versus right before it. It looks at which timing might work better for people on hemodialysis.
HawalliAges 21–65 - NCT07360938Recruiting
How inflammation affects drug processing
This study looks at how inflammation from conditions like diabetes, IBD, or kidney disease affects the way drugs work in the body. It may help improve dosing and safety for patients with these conditions.
Indianapolis, IndianaAges 12–99 - NCT06861816Recruiting
Walking with dogs for teens on dialysis
This study looks at whether a program of walking with dogs can help teenagers on dialysis breathe easier and feel less tired. It focuses on how the program might improve your lungs and your ability to be active.
Dokki, Giza GovernorateAges 13–17 - NCT06868888Recruiting
Red blood cell function in kidney failure
This study looks at how red blood cells work in people with end-stage kidney disease who are on hemodialysis. It aims to understand blood flow and may help guide future treatments.
TaoyuanAges 20 years+ - NCT07291154Recruiting
Using an app to improve dialysis quality
This trial tests if a smartphone app (via WeChat) can help people on dialysis better manage their treatment and improve quality of care. It's for adults who have been on regular dialysis for at least 3 months.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT06906835Recruiting
Comparing two blood tests to guide iron treatment in dialysis patients
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
Pathumwan, BangkokAges 18–80 - NCT07224763RecruitingPhase 1/Phase 2
Pig kidney transplant trial for kidney failure patients
This trial tests a genetically modified pig kidney (Thymokidney) for people with end-stage kidney disease who are on dialysis. It aims to see if this new type of transplant is safe and effective for those who cannot get a human kidney.
New York, New YorkAges 40–70 - NCT07206524Recruiting
Testing magnesium in dialysis fluid for people in OMAGOD study
This trial is for people already enrolled in the OMAGOD pilot study. It tests whether changing the amount of magnesium in a special dialysis fluid can reduce unwanted blood clotting and inflammation during dialysis.
BrusselsAges 18 years+ - NCT07201467RecruitingPhase 1/Phase 2
KN060 for dialysis patients with kidney failure
This study tests an experimental drug called KN060, given to people with end-stage kidney disease on dialysis, to see if it is safe and helps with blood clotting. It may be an option if you are on stable dialysis and not at high risk for bleeding.
Beijing, Beijing MunicipalityAges 18–80 - NCT07157397Recruiting
Plant-based diet for nutrition on dialysis
This study tests if eating more plant-based foods can improve nutrition in people on peritoneal dialysis who are underweight or malnourished. Participants will follow a special diet plan and have regular health check-ups for 6 months.
Cheras, Kuala LumpurAges 18 years+ - NCT07153939Recruiting
Study of a new device to create dialysis access
This trial tests a new device called the Velocity pAVF System that creates a connection between a vein and artery in your arm for hemodialysis. If you need dialysis now or within the next 6 months, this could be a new option for you.
Dothan, AlabamaAges 18–80 - NCT07146854Recruiting
EndoForce Connector Study for Dialysis Graft Access
This study is testing a new connector system (EndoForce) used during dialysis graft placement in people with kidney failure. Researchers want to make sure it works safely and effectively in real-world use.
Orangeburg, South CarolinaAges 18 years+ - NCT06917950RecruitingPhase 1/Phase 2
Roxadustat for bone and brain health in dialysis patients
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
Al Mansurah, DakahliyaAges 18 years+
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for end stage renal disease?
- Yes. Clin2 currently lists 145 recruiting end stage renal disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a end stage renal disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a end stage renal disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.